Home Current Issue Previous Issues Published Ahead-of-Print Supplements Collections Podcasts Video Journal Info
Skip Navigation LinksHome > March 2011 - Volume 68 - Issue 3 > Neuroprotective Effects of Bone Marrow Stem Cells Overexpres...
Neurosurgery:
doi: 10.1227/NEU.0b013e3182098a8a
Research-Human-Clinical Trials

Neuroprotective Effects of Bone Marrow Stem Cells Overexpressing Glial Cell Line-Derived Neurotrophic Factor on Rats With Intracerebral Hemorrhage and Neurons Exposed to Hypoxia/Reoxygenation

Yang, Chaoxian MD*†; Zhou, Ling MD‡; Gao, Xiaoqing MD†; Chen, Bo MD†; Tu, Jiangyi MD†; Sun, Hengyun PhD§; Liu, Xiaoqing PhD∥; He, Jing MD¶; Liu, Juan MD¶; Yuan, Qionglan PhD¶#

Collapse Box

Abstract

BACKGROUND: Intracerebral hemorrhage (ICH) represents at least 15% of all strokes in the Western population and a considerably higher proportion at 50% to 60% in the Oriental population.

OBJECTIVE: To investigate whether administration of bone marrow stem cells (BMSCs) overexpressing glial cell line–derived neurotrophic factor (GDNF) provides more efficient neuroprotection for rats with ICH and neurons exposed to hypoxia/reoxygenation.

METHODS: Primary rat BMSCs were transfected with rat GDNF gene using virus vector (GDNF/BMSCs) and blank virus plasmid (BVP/BMSCs). Primary rat cortical neurons of rats were exposed to hypoxia and then reoxygenated with GDNF/BMSCs (GDNF/BMSCs group) or BVP/BMSCs (BMSCs group) treatment for 12 hours and 1, 2, 3, and 5 days. Hoechst 33258 staining was used to evaluate apoptosis. GDNF/BMSCs, BVP/BMSCs, and saline (GDNF/BMSCs, BMSCs, and control groups) were injected into the right striatum 3 days after rat ICH induced by injecting collagenase. Modified neurological severity scores and hematoxylin and eosin staining were performed to evaluate neurological function and lesion volume at 1 and 2 weeks after transplantation. Immunostaining was used to observe differentiation of grafted cells (neurofilament-200 for neurons, glial fibrillary acidic protein for astrocytes). The GDNF level and apoptosis were evaluated by Western blotting and terminal deoxynucleotidyl transferase dUTP nick-end labeling, respectively.

RESULTS: The GDNF/BMSCs group had significantly lowered apoptosis compared with the BMSCs group at the given time. The GDNF/BMSCs group had significantly improved functional deficits and reduced lesion volume compared with the BMSCs group. Stable GDNF expression in the GDNF/BMSCs group was detected at the given time in the host brain. The neurofilament-positive grafted cells in the GDNF/BMSCs group were more numerous than in the BMSCs group. The GDNF/BMSCs group had significantly decreased apoptotic cells compared with the BMSCs group.

CONCLUSION: These results suggest that GDNF/BMSCs provide better neuroprotection for rats with ICH and neurons exposed to hypoxia/reoxygenation.

Copyright © by the Congress of Neurological Surgeons

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.